EIP today announces the appointment of life sciences specialist Monika Rai to further enhance its capabilities in this sector.
Monika joins the EIP partnership from Mathys & Squire LLP. Her professional experience spans over fifteen years and includes private practice as well as in-house experience with GSK.
She has significant experience in opposition proceedings at the EPO often involving multiple parties. Her expertise in the pharmaceutical sector includes representing innovators in the fields of cancer immunotherapy, microbiome therapeutics, gene therapy, nucleotide and peptide vaccines, antibodies, RNAi and diagnostics.
Heather McCann, partner at EIP, said:
“Monika is a very well-respected IP practitioner, and her appointment is a significant addition to EIP’s capabilities in the life sciences sector. Together with partner Gareth Probert, who joined the Life Tech team in February 2020, we are looking forward to Monika playing a key role in the development of the practice."
Monika Rai, partner at EIP, said:
“EIP’s reputation as a modern and agile firm and its representation of clients at the highest levels in ground-breaking areas of patent law is attractive to clients and attorneys alike. I have been impressed by the experience and ethos of the team at EIP and am looking forward to helping develop the firm’s life sciences practice. I am really excited about our life sciences offering combining top-notch contentious and strategic pharma experience with expertise in areas such as artificial intelligence which are of immense interest to this sector.”